MIRM EBITDA Growth
Mirum Pharmaceuticals Inc · EBITDA Growth
MIRM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-4033.61%period ending
MIRM TTM EBITDA YoY % (-397.85% → -4033.61%)
Year-over-year change
High-resolution chart · PNG
MIRM ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -4,033.61% | |
| -1,926.8252% | |
| 128.4959% | |
| 90.9515% | |
| 74.4236% | |
| 70.5552% | |
| 64.1204% | |
| 56.9217% | |
| 52.3635% | |
| -11.4096% | |
| -11.4031% | |
| -366.6423% | |
| -278.1943% | |
| -125.3627% | |
| -87.378% | |
| 81.4506% | |
| 71.4137% | |
| 59.9456% | |
| 35.2768% | |
| -93.0621% | |
| -81.3244% | |
| -82.4308% | |
| -85.2564% | |
| -166.182% | |
| -397.8486% |